Every person who is insured in Germany in a statutory or private health insurance scheme is entitled to be vaccinated. The same applies to persons who have their domicile or usual place of residence in Germany or are employed in Germany. Children under 16 must also be accompanied by a legal guardian. Information on required documents will be provided on the Berlin Service Portal.
The Standing Commission on Vaccination (Stiko) recommends basic immunization against the SARS-CoV-2 coronavirus for all persons of 5 years of age and older. Only in a few exceptions is vaccination not possible. As a rule, the basic immunization results from two vaccinations. The combination of one vaccination and one Covid-19 infection can also be considered as basic immunization. Further information can be found on the website of the Robert Koch Institute.
First booster vaccination
In addition, the Stiko recommends a booster vaccination for all persons of twelve years of age and older. This should take place no earlier than six months after the basic immunization. In Berlin, mainly vaccines from Biontech and Moderna adapted to the Omicron variant are available for the booster vaccination. After the basic immunization with the vaccine Nuvaxovid from Novavmax, the booster vaccine for persons 18 years and older can be Nuvaxovid or Comirnaty from BioNTech/Pfizer. Furthermore, for individuals of 30 years of age and older, Moderna’s Spikevax vaccine can be used for the booster vaccination.
Second booster vaccination
A second booster vaccination is recommended for persons of 60 years of age and older and for persons at risk of severe illness due to a previous medical condition. In Berlin, vaccines from Biontech and Moderna adapted to the Omicron variants are available for the second booster vaccination. To date, only mRNA vaccines have been approved for booster vaccination. For individuals under 60 years of age who have no prior medical condition and have already had three immunologic events (vaccination or disease), no further vaccination is currently recommended. For more information, visit the Robert Koch Institute site.